Weight loss injection for adults with type 2 diabetes and overweight
Part of Hormones & metabolism clinical trials.
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a body mass index (BMI) of 27 or higher
- You have been diagnosed with type 2 diabetes for at least 90 days
- Your blood sugar (HbA1c) is between 6.0% and 10%
- You have tried to lose weight before but were not successful
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine to help adults with obesity or overweight lose weight. It's for people who have had trouble losing weight in the past and don't have diabetes.
This study tests a new medication (AZD6234) added to your current weight-management medication (an incretin-based drug) to see if it helps with weight loss. You may be eligible if you are overweight or obese with related health issues or type 2 diabetes.
This study tests a new injectable medication to help adults with obesity or overweight who don't have diabetes lose weight. It involves a reduced-calorie diet and exercise plan, and may offer an effective treatment option for weight management.
This study tests a new injectable medicine for weight management in adults who are overweight. It aims to see how the medicine works in the body and how it affects weight.
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
This trial tests an investigational injection called ZT003 to see if it is safe and how the body processes it. It is for healthy volunteers or those who are overweight or obese, to help understand how this treatment might work.
Hear when a new Obesity or Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.